HUP9802303A3 - Calcitriol derivatives and their uses - Google Patents

Calcitriol derivatives and their uses

Info

Publication number
HUP9802303A3
HUP9802303A3 HU9802303A HUP9802303A HUP9802303A3 HU P9802303 A3 HUP9802303 A3 HU P9802303A3 HU 9802303 A HU9802303 A HU 9802303A HU P9802303 A HUP9802303 A HU P9802303A HU P9802303 A3 HUP9802303 A3 HU P9802303A3
Authority
HU
Hungary
Prior art keywords
calcitriol derivatives
calcitriol
derivatives
Prior art date
Application number
HU9802303A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/531,403 external-priority patent/US5952317A/en
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of HUP9802303A2 publication Critical patent/HUP9802303A2/hu
Publication of HUP9802303A3 publication Critical patent/HUP9802303A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9802303A 1995-09-21 1996-09-20 Calcitriol derivatives and their uses HUP9802303A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53186795A 1995-09-21 1995-09-21
US08/531,403 US5952317A (en) 1995-09-21 1995-09-21 Calcitriol derivatives and their uses

Publications (2)

Publication Number Publication Date
HUP9802303A2 HUP9802303A2 (hu) 1999-02-01
HUP9802303A3 true HUP9802303A3 (en) 1999-05-28

Family

ID=27063537

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802303A HUP9802303A3 (en) 1995-09-21 1996-09-20 Calcitriol derivatives and their uses

Country Status (9)

Country Link
EP (1) EP1021401A1 (no)
JP (1) JP3372259B2 (no)
KR (1) KR100327922B1 (no)
AU (1) AU717238B2 (no)
CA (1) CA2229316C (no)
HU (1) HUP9802303A3 (no)
NO (1) NO981282L (no)
NZ (2) NZ501318A (no)
WO (1) WO1997011053A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001011986A1 (en) * 1999-08-17 2001-02-22 Wisconsin Alumni Research Foundation Animal feed containing hydrolyzable calcitriol derivatives
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
WO2001040177A2 (en) 1999-12-02 2001-06-07 Women And Infants Hospital Esters of vitamin d3 and uses thereof
US20030195175A1 (en) * 2002-03-25 2003-10-16 Deluca Hector F. Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
CA2557809A1 (en) 2004-03-01 2005-09-09 Bioxell Spa Treatment of interstitial cystitis with vitamin d compounds
EP1812011A1 (en) 2004-11-12 2007-08-01 Bioxell S.p.a. Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
PL3095447T3 (pl) 2006-02-03 2022-02-14 Opko Renal, Llc Leczenie niedoboru lub deficytu witaminy d 25-hydroksywitaminą d2 i 25- hydroksywitaminą d3
ES2497494T3 (es) 2006-06-21 2014-09-23 Opko Renal, Llc Método de tratamiento y prevención del hiperparatiroidismo secundario
JP5444212B2 (ja) 2007-04-25 2014-03-19 シトクロマ インコーポレイテッド ビタミンｄ不足および欠乏症の治療方法
JP5647516B2 (ja) 2007-04-25 2014-12-24 シトクロマ インコーポレイテッド ビタミンｄ療法のための方法および化合物
KR101540369B1 (ko) 2007-04-25 2015-07-29 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
CA2683514C (en) 2007-04-25 2019-07-09 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
EP3112476B1 (en) 2008-04-02 2023-08-02 EirGen Pharma Ltd. Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
SI2552484T1 (sl) 2010-03-29 2020-07-31 Opko Ireland Global Holdings, Ltd. Postopki in sestavki za znižanje ravni paratiroidnega hormona
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
MY198547A (en) 2016-03-28 2023-09-04 Opko Ireland Global Holdings Ltd Methods of vitamin d treatment
KR101983654B1 (ko) * 2018-07-24 2019-05-29 한국과학기술원 Cfc 증후군 환자의 발달 저해를 완화할 수 있는 치료용 조성물
CN114656413B (zh) * 2022-03-30 2024-04-09 南通华山药业有限公司 一种阿法骨化醇杂环酯类衍生物及其制备方法
CN114681467B (zh) * 2022-03-30 2024-03-12 南通华山药业有限公司 一种阿法骨化醇杂环酯类衍生物在制备抗肿瘤药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195027A (en) * 1978-01-16 1980-03-25 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4206131A (en) * 1978-06-19 1980-06-03 The Upjohn Company Compounds and process
US4188345A (en) * 1978-07-26 1980-02-12 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
JPS5846508A (ja) * 1981-09-14 1983-03-18 日本石油化学株式会社 導電性材料の製法
IT1163846B (it) * 1982-07-26 1987-04-08 Wisconsin Alumni Res Found Analoghi della vitamina d
JPH0825993B2 (ja) * 1990-08-20 1996-03-13 大同ほくさん株式会社 ビタミンｄ２およびｄ３又は活性型ビタミンｄ２およびｄ３の製造方法，並びにその中間体
JPH05339230A (ja) * 1992-03-12 1993-12-21 Nisshin Flour Milling Co Ltd 活性型ビタミンｄ２及びその誘導体の製造法
JP3182215B2 (ja) * 1992-06-26 2001-07-03 日清製粉株式会社 １−アシルオキシビタミンｄ誘導体

Also Published As

Publication number Publication date
NZ501318A (en) 2001-07-27
EP1021401A1 (en) 2000-07-26
NZ319819A (en) 2000-02-28
KR19990063628A (ko) 1999-07-26
JP3372259B2 (ja) 2003-01-27
AU7242696A (en) 1997-04-09
WO1997011053A1 (en) 1997-03-27
CA2229316C (en) 2005-04-12
NO981282L (no) 1998-05-22
NO981282D0 (no) 1998-03-20
MX9801943A (es) 1998-08-30
CA2229316A1 (en) 1997-03-27
AU717238B2 (en) 2000-03-23
KR100327922B1 (ko) 2002-05-09
HUP9802303A2 (hu) 1999-02-01
JPH11511475A (ja) 1999-10-05

Similar Documents

Publication Publication Date Title
GB2298422B (en) Compounds and their use
IL122428A0 (en) Minizymes and minribozymes and uses thereof
HUP9802303A3 (en) Calcitriol derivatives and their uses
EP0836617A4 (en) PAREVINES AND TACHYTEGRINES
ZA964862B (en) Optimized minizymes and miniribozymes and uses thereof
EP0744125A3 (en) Iodine complex and its application
GB9526407D0 (en) Substances and their uses
AP9600802A0 (en) Libricant
ZA965962B (en) Anti-piroplasmotic agent
AU1105P (en) DALESE Metrosideros excelsus
GB9500898D0 (en) Substances and their uses
GB9515483D0 (en) Substances and their uses
GB9501010D0 (en) Substances and their uses
GB9512325D0 (en) Substances and their uses
GB9507541D0 (en) Substances and their uses
GB9510392D0 (en) Substances and their uses
GB9512319D0 (en) Substances and their uses
GB9515484D0 (en) Substances and their uses
GB9515482D0 (en) Substances and their uses
GB9504258D0 (en) Substances and their uses
PL307196A1 (en) Pharmaceutcal agent
AU129273S (en) Pendant
AU127251S (en) Sandboard
AU131835S (en) Gamesboard
AU131470S (en) Bedhead